JUL 22, 2015 3:39 PM PDT

Future Stem Cell Factories

WRITTEN BY: Ilene Schneider
When people get sick or hurt, they lose huge numbers of cells. For example, as pointed out in an article in Futurity, "The damage from a major heart attack could cost you around five billion heart cells. Future stem cell treatments will require this number and more to ensure those cells are replaced and improve your chances of survival." Scientists from the University of Nottingham in the United Kingdom have found a completely synthetic substrate that could have the ability to grow billions of stem cells to reproduce them in factory-like fashion (http://feedly.com/i/subscription/feed/http://www.futurity.org/feed/).
Researchers develop methods of mass reproduction of stem cells to provide lifesaving therapy.
The objective is the mass production of human embryonic (pluripotent) stem cells to act as an "off-the-shelf product for clinical use in the treatment of the heart, liver and brain." To make this happen, researchers have been looking for polymers on which to grow human pluripotent stem cells and differentiate them according to function, billions at a time. They used a high throughput materials discovery approach to find the human-made material, free from possible contamination and batch variability.

According to the National Institutes of Health, "Human embryonic stem cells (hESCs) are generated by transferring cells from a preimplantation-stage embryo into a plastic laboratory culture dish that contains a nutrient broth known as culture medium. The cells divide and spread over the surface of the dish. In the original protocol, the inner surface of the culture dish was coated with mouse embryonic skin cells specially treated so they will not divide. This coating layer of cells is called a feeder layer. The mouse cells in the bottom of the culture dish provide the cells a sticky surface to which they can attach. Also, the feeder cells release nutrients into the culture medium. Researchers have now devised ways to grow embryonic stem cells without mouse feeder cells. This is a significant scientific advance because of the risk that viruses or other macromolecules in the mouse cells may be transmitted to the human cells" (http://stemcells.nih.gov/info/basics/pages/basics3.aspx).

According to Morgan Alexander, professor of biomedical surfaces at University of Nottingham, "The possibilities for regenerative medicine are still being researched in the form of clinical trials. What we are doing here is paving the way for the manufacture of stem cells in large numbers when those therapies are proved to be safe and effective."

As Chris Denning, professor of stem cell biology at the University of Nottingham, explains, "The field of regenerative medicine has snowballed in the last five years and over the coming five years a lot more patients will be receiving stem cell treatments. Clinical trials are still in the very early stages. However, with this kind of product, if we can get it commercialized and validated by the regulators it could be helping patients in two to three years."
Researchers are investigating conditions of the heart, liver and brain for potential stem cell therapy. Stem cells are already being used to treat eye disorders.
About the Author
Ilene Schneider is the owner of Schneider the Writer, a firm that provides communications for health care, high technology and service enterprises. Her specialties include public relations, media relations, advertising, journalistic writing, editing, grant writing and corporate creativity consulting services. Prior to starting her own business in 1985, Ilene was editor of the Cleveland edition of TV Guide, associate editor of School Product News (Penton Publishing) and senior public relations representative at Beckman Instruments, Inc. She was profiled in a book, How to Open and Operate a Home-Based Writing Business and listed in Who's Who of American Women, Who's Who in Advertising and Who's Who in Media and Communications. She was the recipient of the Women in Communications, Inc. Clarion Award in advertising. A graduate of the University of Pennsylvania, Ilene and her family have lived in Irvine, California, since 1978.
You May Also Like
SEP 16, 2022
Genetics & Genomics
Grad Student Highlights: Shannon Barry (Florida Institute of Technology)
SEP 16, 2022
Grad Student Highlights: Shannon Barry (Florida Institute of Technology)
This interview series is focused on the graduate student experience across all STEM fields that allows them to get their ...
SEP 15, 2022
Infographics
The Domestication of Dogs
SEP 15, 2022
The Domestication of Dogs
Modern dogs, which have descended from a now-extinct lineage of wolves, are often called “man’s best friend& ...
OCT 08, 2022
Coronavirus
Carriers of Certain APOE Variants are More Vulnerable to Severe COVID-19
OCT 08, 2022
Carriers of Certain APOE Variants are More Vulnerable to Severe COVID-19
Researchers have long known that certain things are risk factors for severe cases of COVID-19, such as old age or obesit ...
OCT 25, 2022
Cell & Molecular Biology
Liver Disease Discovery Resolves Controversy
OCT 25, 2022
Liver Disease Discovery Resolves Controversy
Liver diseases are a serious health problem. Chronic liver disease is estimated to impact over 1.5 billion people.
NOV 02, 2022
Genetics & Genomics
Want to advance your miRNA research?
NOV 02, 2022
Want to advance your miRNA research?
miRNAs as potential biomarkers MicroRNAs (miRNAs) are non-coding RNAs, 18-26 nucleotides long. They play an important ro ...
NOV 15, 2022
Genetics & Genomics
Revealing the Mutations that Make Melanoma Immortal
NOV 15, 2022
Revealing the Mutations that Make Melanoma Immortal
Telomeres cap the ends of chromosomes, preventing breakage. Some cancer cells can use those protective caps to their adv ...
Loading Comments...